The digital well being report (EHR) is a contributor to critical affected person hurt occurring inside a sociotechnical system. Chemotherapy ordering is a high-risk process due to the complicated nature of ordering workflows and potential detrimental results if mistaken chemotherapeutic doses are administered. Many chemotherapy ordering errors can’t be mitigated by systems-based modifications due to the restricted extent to which particular person establishments are ready to customise proprietary EHR software program. We hypothesized that simulation-based coaching may enhance suppliers’ means to establish and mitigate frequent chemotherapy ordering errors.
Pediatric hematology/oncology suppliers voluntarily participated in simulations utilizing an EHR testing (“Playground”) surroundings. The variety of security dangers recognized and mitigated by every supplier at baseline was recorded. Risks had been reviewed one-on-one after preliminary simulations and at a gaggle “lunch-and-learn” session. At three-month follow-up, repeat simulations assessed for enhancements in error identification and mitigation, and suppliers had been surveyed about prevention of real-life security occasions.
The Eight collaborating suppliers recognized and mitigated a mean of 5.5 out of 10 security dangers through the preliminary simulation, in contrast 7.four security dangers on the observe up simulation (p=0.030). Two of the suppliers (25%) reported stopping a minimum of one real-world affected person security occasion within the scientific setting on account of the preliminary coaching session. Simulation-based coaching might reduce suppliers’ susceptibility to chemotherapy ordering security vulnerabilities inside the EHR. This method could also be used when systems-based EHR enhancements are usually not possible due to restricted means to customise native cases of proprietary EHR software program.
Evaluation of Inflammatory Biomarkers in Pediatric Hematology–Oncology Patients With Bloodstream Infection
Bloodstream an infection (BSI) is a critical complication in pediatric hematology–oncology sufferers. To consider the scientific significance of C-reactive protein (CRP), procalcitonin (PCT), albumin, fibrinogen, and D-dimer as potential biomarkers to differentiate amongst varied subtypes of BSIs in pediatric sufferers with hematological and oncological illnesses, we retrieved and analyzed the medical information of pediatric hematology–oncology sufferers identified with BSI at our hospital between January 2016 and December 2017.
The demographic (intercourse and age) and scientific (major illnesses) traits, and laboratory check outcomes (white blood cell and absolute neutrophil counts, and serum CRP, PCT, albumin, fibrinogen, and D-dimer ranges) had been in contrast between nosocomial and non-nosocomial; neutropenic and non-neutropenic; and gram-positive and gram-negative BSI episodes. Of the 5 potential biomarkers evaluated (CRP, PCT, albumin, fibrinogen, and D-dimer), PCT ranges had been considerably decrease in neutropenic episodes and gram-positive BSIs (P=0.008 and P=0.001, respectively).
A complete of 125 BSI episodes had been included, together with 69 (55.2%) nosocomial circumstances, 94 (75.2%) neutropenic circumstances, and 49 (39.2%) gram-positive episodes. At a cutoff worth of 0.67 ng/mL, the diagnostic sensitivity, specificity, and optimistic/damaging predictive values of PCT for the differentiation of gram-positive and gram-negative bacterial sepsis had been 74.2%, 64.6%, 70.8%, and 65.2%, respectively. We concluded that PCT may probably function a biomarker to differentiate between gram-positive and gram-negative BSIs in pediatric hematology–oncology sufferers.
Development of a instrument to allocate inpatient specialised pharmacy assets at a complete most cancers middle
Develop an goal instrument to align the wants of inpatient providers at a Comprehensive Cancer Center with the accessible assets of hematology/oncology scientific specialist pharmacists. The shift of the pharmacy career from product-centered to patient-centered care has expanded the scope of observe of the scientific pharmacist and their means to focus on a therapeutic space. However, these specialised assets are restricted. The pharmacy division at The James Comprehensive Cancer Center at The Ohio State University Wexner Medical Center developed a instrument to objectively decide which inpatient providers would obtainessentially the mostprofit from having a hematology/oncologyscientific specialist pharmacist on their healthcare group.
A Steering Committee was created to decide the required metrics wanted throughout the 29 inpatient providers at The James, and knowledge was collected from the digital medical report. The metrics evaluated had been: affected person acuity, inpatient intravenous anticancer administrations, inpatient oral anticancer administrations, presence of an outpatient anticancer therapy plan for sufferers admitted for an inpatient keep, and the usage of high-risk hematology/oncology therapies.
MIPT3 Antibody |
|||
| MBS853423-01mg | MyBiosource | 0.1mg | EUR 305 |
MIPT3 Antibody |
|||
| MBS853423-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
MIPT3 Antibody |
|||
| MBS853423-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
MIPT3 Antibody |
|||
| MBS853423-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
MIPT3 Antibody |
|||
| MBS853423-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
MIPT3 Antibody |
|||
| MBS9505833-005mL | MyBiosource | 0.05mL | EUR 285 |
MIPT3 Antibody |
|||
| MBS9505833-01mL | MyBiosource | 0.1mL | EUR 385 |
MIPT3 Antibody |
|||
| MBS9505833-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
MIPT3 antibody |
|||
| 70R-33832 | Fitzgerald Industries International | 100 ug | Ask for price |
MIP-T3 Antibody |
|||
| C13085-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: MIP-T3 Rabbit Polyclonal Antibody |
|||
MIP-T3 Antibody |
|||
| C13085-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: MIP-T3 Rabbit Polyclonal Antibody |
|||
MIP-T3 Polyclonal Antibody |
|||
| ABP54468-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270 |
|||
MIP-T3 Polyclonal Antibody |
|||
| ABP54468-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270 |
|||
MIP-T3 Polyclonal Antibody |
|||
| ABP54468-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270 |
|||
MIP-T3 Polyclonal Antibody |
|||
| BT-AP05430-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules. |
|||
MIP-T3 Polyclonal Antibody |
|||
| BT-AP05430-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules. |
|||
MIP-T3 Polyclonal Antibody |
|||
| BT-AP05430-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules. |
|||
MIP-T3 Polyclonal Antibody |
|||
| JOT-AP05430-100ul | Jotbody | 100ul | EUR 220 |
|
Description: Human |
|||
MIP-T3 Polyclonal Antibody |
|||
| JOT-AP05430-50ul | Jotbody | 50ul | EUR 144 |
|
Description: Human |
|||
MIP-T3 Polyclonal Antibody |
|||
| E44H05276 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
MIP-T3 Polyclonal Antibody |
|||
| E20-72768 | EnoGene | 100ug | EUR 225 |
|
Description: Available in various conjugation types. |
|||
MIP-T3 Polyclonal Antibody |
|||
| MBS8523749-01mg | MyBiosource | 0.1mg | EUR 305 |
MIP-T3 Polyclonal Antibody |
|||
| MBS8523749-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
MIP-T3 Polyclonal Antibody |
|||
| MBS8523749-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
MIP-T3 Polyclonal Antibody |
|||
| MBS8523749-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
MIP-T3 Polyclonal Antibody |
|||
| MBS8523749-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
MIP-T3 Polyclonal Antibody |
|||
| UB-GEN-3875 | UpingBio | 100 ul | EUR 200 |
Rapid Human Antibody Isotyping Kit, 5pk |
|||
| 113101 | Antibody Research Corporation | 5 PKS | Ask for price |
MIP-T3 Rabbit Polyclonal Antibody |
|||
| ES5467-100ul | ELK Biotech | 100ul | EUR 124 |
|
Description: IHC, IF, ELISA |
|||
MIP-T3 Rabbit Polyclonal Antibody |
|||
| ES5467-50ul | ELK Biotech | 50ul | EUR 74 |
|
Description: IHC, IF, ELISA |
|||
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) |
|||
| MBS643331-02mL | MyBiosource | 0.2mL | EUR 695 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) |
|||
| MBS643331-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
Anti-MIPT3 TRAF3IP1 Antibody |
|||
| A08944 | BosterBio | 100ul | EUR 335 |
|
Description: Boster Bio Anti-MIPT3 TRAF3IP1 Antibody (Catalog# A08944). Tested in WB, IHC-P, IF, ICC, ELISA applications. This antibody reacts with Human, Rat, Mouse. |
|||
Anti Human Alpha 1Anti Human Chymotrypsin Pab |
|||
| 111444 | Antibody Research Corporation | 100 µg | Ask for price |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (AP) |
|||
| MBS6357857-02mL | MyBiosource | 0.2mL | EUR 980 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (AP) |
|||
| MBS6357857-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (PE) |
|||
| MBS6357867-02mL | MyBiosource | 0.2mL | EUR 980 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (PE) |
|||
| MBS6357867-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (APC) |
|||
| MBS6357858-02mL | MyBiosource | 0.2mL | EUR 980 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (APC) |
|||
| MBS6357858-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (Biotin) |
|||
| MBS6357859-02mL | MyBiosource | 0.2mL | EUR 980 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (Biotin) |
|||
| MBS6357859-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (FITC) |
|||
| MBS6357860-02mL | MyBiosource | 0.2mL | EUR 980 |
TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (FITC) |
|||
| MBS6357860-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Anti Human LH Pab |
|||
| 111053 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human C3 Mab |
|||
| 111163 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human C5 Mab |
|||
| 111164 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TF Pab |
|||
| 111263 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human LYN Mab |
|||
| 831082 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FYN Mab |
|||
| 831084 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PSA Pab |
|||
| 165726 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD2 Mab |
|||
| 272062 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human C4a Mab |
|||
| 272103 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FSH Mab |
|||
| 272142 | Antibody Research Corporation | 1 mg | Ask for price |
Anti Human FSH Pab |
|||
| 272143 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CPD Pab |
|||
| 272458 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human IgE Mab |
|||
| 121026 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PAI Pab |
|||
| 164045 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Tau Mab |
|||
| 164070 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human BNP Pab |
|||
| 165460 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human C4d Pab |
|||
| 165468 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD2 Pab |
|||
| 165486 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD7 Pab |
|||
| 165491 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CEA Pab |
|||
| 165493 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CK7 Pab |
|||
| 165510 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human EGF Pab |
|||
| 165555 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Tau Pab |
|||
| 111112 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human p53 Pab |
|||
| 111304 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FLK Pab |
|||
| 111462 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human C4b Pab |
|||
| 111488 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD8 Pab |
|||
| 111494 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Mu2 Pab |
|||
| 111499 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human ROS Pab |
|||
| 111519 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FGR Pab |
|||
| 111676 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human JUN Pab |
|||
| 111686 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human LYN Pab |
|||
| 111689 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human MET Pab |
|||
| 111693 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human MYC Pab |
|||
| 111694 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human REL Pab |
|||
| 111712 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CA 15-3 Pab |
|||
| 165469 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CA 19-9 Pab |
|||
| 165470 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CA 72-4 Pab |
|||
| 165471 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PAK1 Mab |
|||
| 831081 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CDK2 Mab |
|||
| 831085 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human LDH1 Pab |
|||
| 165614 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Muc2 Pab |
|||
| 165669 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Muc4 Pab |
|||
| 165670 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human NGFR Pab |
|||
| 165682 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PAX5 Pab |
|||
| 165709 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PAX8 Pab |
|||
| 165710 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PTEN Pab |
|||
| 165729 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TLR2 Pab |
|||
| 165782 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TLR9 Pab |
|||
| 165783 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GCSF Mab |
|||
| 181038 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GRK5 Mab |
|||
| 272242 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human KLK8 Pab |
|||
| 272446 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human KLK8 Mab |
|||
| 272447 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD47 Mab |
|||
| 161740 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Flk1 Pab |
|||
| 162168 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human MMP7 Pab |
|||
| 162385 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FSHR Pab |
|||
| 164038 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Muc1 Pab |
|||
| 164043 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human UGRP Pab |
|||
| 164048 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TIM1 Pab |
|||
| 164072 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human FABP Pab |
|||
| 164279 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GP73 Pab |
|||
| 164281 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CASR Mab |
|||
| 164515 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD77 Pab |
|||
| 164516 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human RHCT Mab |
|||
| 165185 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Tim3 Pab |
|||
| 165188 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human ASIC Mab |
|||
| 165379 | Antibody Research Corporation | 1 mg | Ask for price |
Anti Human ASIC Pab |
|||
| 165380 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD6 [2G11] |
|||
| 165383 | Antibody Research Corporation | 1 mg | Ask for price |
Anti Human Bcl2 Pab |
|||
| 165448 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human BCMA Pab |
|||
| 165449 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human BMP9 Pab |
|||
| 165459 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Braf Pab |
|||
| 165463 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD15 Pab |
|||
| 165485 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD38 Pab |
|||
| 165487 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD47, Pab |
|||
| 165488 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD54 Pab |
|||
| 165489 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD57 Pab |
|||
| 165490 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CK20 Pab |
|||
| 165509 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CKMM Pab |
|||
| 165511 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human EGFR Pab |
|||
| 165556 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD38 Mab |
|||
| 100117 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD22 Mab |
|||
| 100161 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GCSF Pab |
|||
| 111054 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human IGF1 Pab |
|||
| 111091 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human NKX2.2 Pab |
|||
| 111171 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CBX4 Pab |
|||
| 111235 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD20 Pab |
|||
| 111237 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD34 Pab |
|||
| 111290 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD44 Pab |
|||
| 111292 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD45 Pab |
|||
| 111293 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GFAP Pab |
|||
| 111298 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Toso Mab |
|||
| 111313 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PICP Pab |
|||
| 111508 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PINP Pab |
|||
| 111509 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human IL35 Pab |
|||
| 111516 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GDF9 Pab |
|||
| 111520 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CD90 Mab |
|||
| 111529 | Antibody Research Corporation | 1 mg | Ask for price |
Anti Human Cul1 Pab |
|||
| 111534 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human Cul3 Pab |
|||
| 111535 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human GLP1 Pab |
|||
| 111544 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TFPI Mab |
|||
| 111563 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human SUMO Mab |
|||
| 111588 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human TFPI Pab |
|||
| 111636 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human CDH1 Pab |
|||
| 111663 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human IL1B Pab |
|||
| 111683 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human LMNA Pab |
|||
| 111687 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human MCL1 Pab |
|||
| 111692 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PCNA Pab |
|||
| 111702 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human PTK2 Pab |
|||
| 111710 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human RELA Pab |
|||
| 111713 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Human RXRA Pab |
|||
| 111714 | Antibody Research Corporation | 100 µg | Ask for price |
Natural killer (NK) perform defects have been seen in lots of hematological malignancies, together with acute myeloid leukemia (AML). AML is related to poor human leukocyte antigen (HLA) expression on leukemia blasts which grow to be targets for killing by NK and pure killer-like T (NKT) cells. However, NK and NKT cells are usually not efficient in killing autologous leukemia blasts, possibly due to quantity or practical abnormalities. The intention of the work was to detect the quantity and proportion of NK and NKT cells in sufferers with AML and the affect of their proportion on the prognosis, response to therapy and survival.
Bone marrow and peripheral blood samples had been collected from 50 grownup sufferers identified as de novo AML who introduced to the Hematology Unit within the Oncology Center Mansoura University (OCMU) at time of analysis. NK and NKT cells had been detected by utilizing immunophenotyping by expression of cell floor and cytoplasmic markers (anti-CD3 fluorescein isothiocyanate (FITC), anti-CD16/56 phycoerythrin (PE)).